Recently, the fifth "Blue Star" innovation and high growth enterprise selection activity came to an end, and Qingdao Seawit Life Science Co., Ltd. was successfully selected.
Qingdao Seawit Life Science Co., Ltd. relies on the rich marine resources, we are committed to developing DHA, Ara and other microbial functional lipids and their microcapsule powder, as well as fish oil, krill oil and other marine biological functional lipid powder, which can be widely used in infant formula food, health care products, medical grade fat emulsion, special medical food, edible oil and other fields.
"Blue Star" innovative high growth enterprise selection activity is guided by Qingdao Municipal venture capital guidance fund management center, hosted by Qingdao equity and venture capital industry association, and undertaken by Qingdao Institute of finance. By building a bridge between enterprises and capital, the activity is committed to providing Qingdao's innovative and high-growth enterprises with all-round one-stop services on the way to the capital market, including equity investment, four board listing, bank credit, brand building, strategic consulting, capital "+" series gold medal training programs, etc., helping enterprises enter the fast lane of development, solving the needs of enterprise financing development, and providing all-round services Strive to build the "preparatory corps" of listed enterprises and help the transformation of new and old kinetic energy for rapid development.
The roadshow attracted a number of enterprises covering the new generation of information technology, advanced manufacturing, biology and medicine, new energy and new materials, modern ocean and other key industries of energy conversion. At the same time, it also attracted many investment institutions, including nearly 10 investment institutions such as yongwan asset, Gaochuang capital, Zhongming capital, Guotai Junan Securities and representatives from banks. The enterprises and the capital side participated in the docking together to solve the capital problems for the majority of high-tech enterprises, so that the enterprises can concentrate on development without worries.